Search

1 to 10 of 123
Sort by


Library Entry
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a review that provides expert perspective on the significance and clinical considerations of CAR T cell therapies in order to provide timely information to clinicians about this revolutionary new therapeutic class. Authors: ...



Web Page
Lymphoma

SUmmary Current Guideline Subcommittee The SITC Cancer Immunotherapy Guidelines Lymphoma Subcommittee will soon convene to develop a consensus statement specific to lymphoma. Current Guideline New Guideline in Progress Cancer Immunotherapy Guidelines Lymphoma Subcommittee...


Web Page
Multiple Myeloma

SUmmary Current Guideline Subcommittee The SITC Cancer Immunotherapy Guidelines Multiple Myeloma Subcommittee will soon convene to develop a consensus statement specific to multiple myeloma. Current Guideline New Guideline in Progress Cancer Immunotherapy Guidelines Multiple Myeloma...


Library Entry
2018 Advances in Cancer Immunotherapy™ - Boston, MA

2018 Advances in Cancer Immunotherapy TM - Boston, MA September 27, 2018 Wyndham Boston Beacon Hill Program Organizers Elizabeth Buchbinder, MD - Dana-Farber Cancer Institute David F. McDermott, MD - Beth Israel Deaconess Medical Center Virginia Seery, MSN, RN, ANP-BC - Beth Israel...

17 attachments



Event
CSCO-CAHON-SITC Joint Session

Presented by the Chinese Society of Clinical Oncology (CSCO) in collaboration with the Chinese American Hematologist and Oncologist Network (CAHON) and the Society for Immunotherapy of Cancer (SITC). The 8th CSCO-CAHON-SITC Joint Symposium in Immuno-oncology is part of the CSCO 21st...

 09-21-2018 | 08:30 - 10:15 CN
 Xiamen


Library Entry
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article authors aimed to identify MHC class I neoepitopes derived from mCALR and isolate TCRs against such neoepitopes with the potential to be utilized clinically for TCR gene therapy. Authors: Vanessa M. Tubb, ...